Nuvo Pharmaceuticals Inc NRIFF

RE:RE:NRI Endgame

[mybikeisorange]

consultant99 wrote: I think that Nuvo had a window of opportunity to do most and maybe all of WF10 development on their own; expanding the shareholder base with a US listing, repairing years of damage to management's reputation, and most of all delivering shareholder value.

Didn't happen. Not only did we not get a reversal of fortunes but rather we got a verification of why the company is where it is today trading at below cash value; a shadow of its former self.I guess it is pretty apparent now why the company hedged on the NASDAQ listing - there was a real concern that the trial might fail.

If resources were not limited they could do trials in the southern hempishere to make up time and use multi-country locations to ensure no repeats of 2014. The problem is that management is snake-bit. They had two FDA failures with Pennsaid before a three month delay and eventual approval. Pliaglis did not achieve FDA approval on the first attempt (Nuvo's fault or partner). Then it was Pennsaid 2% (Nuvo's fault or partner) failing to get FDA approval the first time around. Now it is the WF10 phase IIb trial. Why would a new investor or anyone else think they can deliver WF10 with out further regulatory delays after this latest setback.

Time is critical - for shareholders. Not so with management that continues to be well compensated with salary and bonuses that are dolled out independently of shareholder value and disasters like Zars and Synera marketing which take the company away from its core business of drug development.

Considering the first phase II WF10 trial was completed in 2010 it took another 3 years before the next one. There was no patent protection in 2010 but they did the trial regardless. While some look at Tina as the genuis that figured out how to get patent protection in the US for WF10 was it  a failure of management not to seek out external expertise before they hired her?

Sch your worst fear of a takeover at $9 or $10 would be a welcome exit for me. I had orders in to sell 35% of my holdings between $9 and $10 last Friday any way- something just didn't feel right with the way the stock traded and closed Thursday. Others I am in regular contact had similar concerns. It was a constant internal battle between greed (getting the maximum value from WF10) and fear (something was going to get screwed up). This is the fifth failure since I have been a shareholder and each time I convince myself it can't happen again - law of averages will prevail.

My biggest fear in selling is the regret that after all I have been through management might actual deliver that home run and the share price spikes to something approaching its true potential value. At least a takeover would take that decision out of my hands and I would find internal peace.

Disagree with the bolded. There are always risks, but if it was a "real concern that the trial might fail", they never would have initiated it in the first place. Unfortunately, Nuvo is forced to do a clinical trial that is dependent on a collaboration with Mother Nature. Sometimes she doesn't cooporate.